Katrine Bosley
InvestorFounderVenture Partner at Advent Life Sciences · Board director at Genocea Biosciences
About
Katrine Bosley is a biotech entrepreneur with over 30 years in the industry. She was CEO of Editas Medicine, which she led from its early stages through its IPO and into clinical development of the first in vivo CRISPR-based medicine, and previously served as CEO of Avila Therapeutics through its acquisition by Celgene. Earlier in her career she was Entrepreneur-in-Residence at The Broad Institute, VP of Business Development at Adnexus Therapeutics/Bristol Myers-Squibb, and held roles at Biogen, Highland Capital Partners, and Alkermes; she is a Cornell University graduate.
Invests in
Biotech
Board director at Genocea Biosciences
Intro paths
In turn, Katrine can intro founders to Genocea Biosciences's investors below.
Deals · 1
Genocea BiosciencesBoard seat
via Advent Life Sciences · filed Feb 2019 · $15M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Investor
DaCapo Brainscience
Sources: the firm's website · SEC Form D filings.
Colleagues at Advent Life Sciences
Frequently asked questions
- Who is Katrine Bosley?
- Katrine Bosley is a biotech entrepreneur with over 30 years in the industry. She was CEO of Editas Medicine, which she led from its early stages through its IPO and into clinical development of the first in vivo CRISPR-based medicine, and previously served as CEO of Avila Therapeutics through its acquisition by Celgene. Earlier in her career she was Entrepreneur-in-Residence at The Broad Institute, VP of Business Development at Adnexus Therapeutics/Bristol Myers-Squibb, and held roles at Biogen, Highland Capital Partners, and Alkermes; she is a Cornell University graduate.
- Where does Katrine Bosley work?
- Katrine Bosley is Venture Partner at Advent Life Sciences and Board director at Genocea Biosciences.
- What does Katrine Bosley invest in?
- Katrine Bosley invests in Biotech.
- What boards does Katrine Bosley sit on?
- Katrine Bosley holds tracked board seats at Arrakis Therapeutics, Genocea Biosciences, Genocea Biosciences.
- What companies has Katrine Bosley invested in?
- Investments tracked here include DaCapo Brainscience.